Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TOP1 | P11387 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 2/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mannitol SCHEMBL2477078 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL2297640 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Sorbitol SCHEMBL763 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL20594083 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL20594082 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL23066399 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL13187369 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL21837180 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL20567656 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL12455929 | 1.00 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116083450-A | Mannitol anabolism combined gene and combined enzyme | 中国海洋大学 | 2023-05-09 | — | — | CN | claimed |
| EP-3272345-B1 | SOLID PREPARATION CONTAINING ANTIOXIDANT AGENT | DAIICHI SANKYO CO LTD (JP) | 2019-10-16 | — | — | EP | claimed |
| EP-3078667-B1 | FORMULATION OF BORONIC ACID COMPOUNDS | THE UNITED STATES OF AMERICA REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES (US) | 2018-11-21 | — | — | EP | claimed |
| EP-1355910-B1 | FORMULATION OF BORONIC ACID COMPOUNDS | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) | 2011-03-09 | — | — | EP | claimed |
| EP-1229917-B1 | PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS FOR TREATMENT OF METABOLIC BONE DISEASE | YUYU PHARMA INC (KR) | 2008-12-17 | — | — | EP | claimed |
| CN-118256519-A | Application of disease-resistant related protein TaMYB22 in regulation and control of plant stripe rust resistance | 西北农林科技大学深圳研究院 | 2024-06-28 | — | — | CN | disclosed |
| CN-114950391-B | Modified silica gel stationary phase, hydrophilic chromatographic column, and preparation method and application thereof | 襄阳市中心医院 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024040356-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-02-29 | — | — | WO | disclosed |
| CN-111500619-B | Application of BXL gene or encoded protein thereof | 中国科学院分子植物科学卓越创新中心 | 2023-06-23 | — | — | CN | disclosed |
| CN-116083450-A | Mannitol anabolism combined gene and combined enzyme | 中国海洋大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-114088855-B | Feces biomarker for early diagnosis of tibial cartilage dysplasia of broiler chicken and application thereof | 河南农业大学 | 2022-10-28 | — | — | CN | disclosed |
| CN-110129322-B | Bna-miR393 application in regulation and control of brassica napus reproductive organ development process | 扬州大学 | 2022-08-26 | — | — | CN | disclosed |
| EP-1401532-A1 | METHOD FOR NON-INVASIVELY DETERMINING THE RELATIVE LEVELS OF TWO BIOLOGICAL SUBSTANCES | UNIVERSITE DE GENEVE (CH) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003019198-A2 | METHODS RELATING TO TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LTD (GB) | 2003-03-06 | — | — | WO | disclosed |
| WO-2003000340-A1 | METHOD FOR NON-INVASIVELY DETERMINING THE RELATIVE LEVELS OF TWO BIOLOGICAL SUBSTANCES | UNIVERSITE DE GENEVE (CH) | 2003-01-03 | — | — | WO | disclosed |
| EP-0920529-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | The University of Lincolnshire & Humberside (GB) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998007882-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | THE UNIVERSITY OF LINCOLNSHIRE & HUMBERSIDE (GB) | 1998-02-26 | — | — | WO | disclosed |
| US-5573777-A | Pulverulent mannitol of moderate friability and process for its preparation | ROQUETTE FRERES (FR) | 1996-11-12 | — | — | US | disclosed |
| US-4661647-A | FREE FROM BINDER | ROQUETTE FRERES (FR) | 1987-04-28 | — | — | US | disclosed |
| US-4460683-A | IMMOBILIZED ENZYMES, POLYSACCHARIDES, POLYUINYL PYRROLIDONE | BOEHRINGER MANNHEIM GMBH (DE) | 1984-07-17 | — | — | US | disclosed |